139 related articles for article (PubMed ID: 3061035)
1. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
Scheffler P; Birkel L; Grub KR; de la Hamette D
Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
[No Abstract] [Full Text] [Related]
2. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
3. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
4. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
[TBL] [Abstract][Full Text] [Related]
5. [Duplex ultrasound measurement of morphologic parameters before and following repeated puncture of the femoral artery for intermittent infusion therapy].
Ranke C; Creutzig A; Alexander K
Vasa; 1990; 19(3):203-6. PubMed ID: 2238813
[TBL] [Abstract][Full Text] [Related]
6. [Prostaglandin E1 in intermittent claudication].
Scheffler P; de la Hamette D; Rogatti W
Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
[No Abstract] [Full Text] [Related]
7. Therapeutic efficacy of intravenously applied prostaglandin E1.
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
[TBL] [Abstract][Full Text] [Related]
8. [Noninvasive, quantitative flow measurement of the femoral artery: significance for the diagnosis and therapy of peripheral arterial occlusive disease].
Scheffler P; Grub KR; De la Hamette D; Kettenbaum F
Vasa Suppl; 1988; 23():103-7. PubMed ID: 3061034
[No Abstract] [Full Text] [Related]
9. [Hemodynamic effects of intermittent intra-arterial infusion treatment with prostaglandin E1 in peripheral arterial occlusive disease].
Ranke C; Creutzig A; Alexander K
Med Klin (Munich); 1991 Jul; 86(7):349-52, 382. PubMed ID: 1921896
[TBL] [Abstract][Full Text] [Related]
10. [Significance of intraoperative duplex sonography for vascular surgery interventions].
Simanowski JH; Mendel V; Heymann H
Z Gastroenterol Verh; 1989 Jul; 24():213-6. PubMed ID: 2474958
[No Abstract] [Full Text] [Related]
11. [The temporal course of hemodynamic changes following intermittent intra-arterial infusion therapy: follow-up based on duplex sonographic parameters].
Ranke C; Creutzig A; Alexander K
Vasa Suppl; 1991; 32():383-5. PubMed ID: 1771540
[No Abstract] [Full Text] [Related]
12. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
Heidrich H; Brodel C; Meuche C; Hellmann G; Ranft J
Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
[No Abstract] [Full Text] [Related]
13. [Experiences with ultra-high dosage fibrinolysis in arterial occlusive disease].
Redecker M; Heinrich F; Fenn K
Vasa Suppl; 1988; 23():182-5. PubMed ID: 3206334
[No Abstract] [Full Text] [Related]
14. [Short- and long-term evaluation of treatment of critical ischemia of the lower lim with PGE1 (alprostadyl alpha-cyclodestrine)].
Amitrano M; Izzo M; Castaldo G; Lombardi R; Tizzano R; Bellizzi AM; Vietri GC; Sorrentino A; D'Avanzo A
Minerva Cardioangiol; 1996; 44(7-8):391-6. PubMed ID: 8965998
[TBL] [Abstract][Full Text] [Related]
15. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
Ranke C; Creutzig A; Alexander K
Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
[No Abstract] [Full Text] [Related]
16. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
[No Abstract] [Full Text] [Related]
17. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
Horsch S; Claeys L
Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
[No Abstract] [Full Text] [Related]
18. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
Dibirov MD
Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
[No Abstract] [Full Text] [Related]
19. [Results of the treatment of peripheral arterial diseases with PGE1].
Borkowski M; Kruk M; Królicki L; Wojtal E; Malmurowicz L; Górewicz R; Laszuk D
Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):505-8. PubMed ID: 2287566
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis for lower extremity arterial and graft occlusions. American College of Radiology. ACR Appropriateness Criteria.
Levy JM; Duszak RL; Akins EW; Bakal CW; Denny DF; Martin LG; Van Moore A; Pentecost MJ; Roberts AC; Vogelzang RL; Kent KC; Perler BA; Resnick MI; Richie J; Becker G
Radiology; 2000 Jun; 215 Suppl():1041-54. PubMed ID: 11037530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
